Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACHL | AZN | AMGN | GILD | BMY |
| Company | Achilles Therapeutics Plc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.4800 | 166.37 | 359.98 | 129.22 | 60.74 |
| High | 1.5000 | 169.49 | 369.32 | 130.54 | 62.05 |
| Low | 1.4450 | 166.04 | 359.21 | 127.61 | 60.45 |
| Latest | 1.4800 | 168.54 | 367.52 | 129.87 | 61.60 |
| Change | +0.0100 | -1.19 | +1.47 | -0.47 | +0.84 |
| % Change | +0.68% | -0.70% | +0.40% | -0.36% | +1.38% |
| Volume | 1,204,100 | 1,401,297 | 1,161,937 | 1,876,670 | 2,357,681 |
| 20-Day Average Volume | 1,689,445 | 2,690,341 | 2,163,008 | 7,249,014 | 10,920,597 |
| Previous Close | 1.4700 | 169.73 | 366.05 | 130.34 | 60.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4047 | 178.46 | 363.73 | 130.78 | 58.56 |
| 20-Day Raw Stochastic | 80.00% | 14.61% | 60.71% | 37.25% | 91.47% |
| 20-Day Relative Strength | 74.12 | 42.10 | 57.33 | 49.13 | 59.82 |
| Weighted Alpha | +34.26 | +5.24 | +20.89 | +8.53 | +29.41 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Buy | 40% Sell | 72% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 72% Buy | 40% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 56% Sell | 40% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.23% since 03/13/25 | -0.30% since 07/16/26 | -1.14% since 07/16/26 | -4.64% since 07/16/26 | +1.92% since 07/16/26 |
| Low | 1.4000 on 03/14/25 | 164.06 on 07/20/26 | 359.70 on 07/23/26 | 127.61 on 07/23/26 | 59.80 on 07/21/26 |
| High | 1.5100 on 03/19/25 | 170.89 on 07/22/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | +6.47% since 02/20/25 | -6.76% since 06/23/26 | +5.86% since 06/23/26 | +3.94% since 06/23/26 | +11.06% since 06/23/26 |
| Low | 1.3600 on 03/04/25 | 164.06 on 07/20/26 | 346.00 on 06/24/26 | 123.67 on 06/25/26 | 54.78 on 06/24/26 |
| High | 1.5100 on 03/19/25 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | +50.85% since 12/20/24 | -12.23% since 04/23/26 | +5.37% since 04/23/26 | -2.74% since 04/23/26 | +4.49% since 04/23/26 |
| Low | 0.9601 on 12/24/24 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.5100 on 03/19/25 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | +42.31% since 09/20/24 | -9.21% since 01/23/26 | +6.56% since 01/23/26 | -4.38% since 01/23/26 | +12.85% since 01/23/26 |
| Low | 0.9200 on 09/25/24 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.5100 on 03/19/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 60,828 | 263,235,600 | 197,560,096 | 161,826,224 | 124,076,232 |
| Shares Outstanding, K | 41,100 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -69,670,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -19,600,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.25 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 11/14/24 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 06/04/25 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.29 | 16.57 | 15.57 | 10.27 |